Research analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a report issued on Monday. The brokerage set a “sell” rating on the medical device company’s stock. Separately, HC Wainwright reissued a “buy” rating and set a $1.60 price target on shares of Avinger in a research report on […]
Avinger, Inc. (NASDAQ:AVGR – Get Free Report) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totalling 69,300 shares, a decline of 29.1% from the July 15th total of 97,800 shares. Currently, 0.6% of the shares of the stock are sold short. Based on […]
Research analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the medical device company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $1.60 price target on shares of Avinger in a report on Friday, […]
StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research report report published on Sunday morning. The brokerage issued a sell rating on the medical device company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $1.60 price target on shares of Avinger in a report on Friday, July […]
Avinger (NASDAQ:AVGR – Get Free Report) and Sight Sciences (NASDAQ:SGHT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Analyst Ratings This is a breakdown of current […]